ClinicalTrials.Veeva

Menu

The SaeboGlove Evaluation Trial (T-SET)

NHS Trust logo

NHS Trust

Status

Unknown

Conditions

Stroke
Cerebral Vascular Disorder
Central Nervous System Diseases
Cardiovascular Diseases
Nervous System Diseases
Vascular Diseases
Brain Diseases

Treatments

Device: SaeboGlove

Study type

Interventional

Funder types

Other

Identifiers

NCT03036033
16/NS/0112 (Other Identifier)
207595 (Other Identifier)
GN16ST162
Res16/A169 (Other Grant/Funding Number)

Details and patient eligibility

About

This study evaluates the safety, feasibility and usability of a SaeboGlove rehabilitation device in the treatment of patients who have reduced ability to open their hand due to weakness after an acute stroke.

Full description

The SaeboGlove is a new rehabilitation aid that can be used in people with hand weakness after a neurological injury. It assists the hand to open, which is crucial for people to grasp, and release everyday objects. It may improve function by doing this but may also help people with severe weakness take part more fully in therapy sessions. This glove is already marketed and is being used in some NHS sites. This trial will assess how it could be used in NHS practice in acute stroke patients and will develop a plan to implement this.

Enrollment

12 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Able to consent
  2. Aged ≥18 years
  3. Diagnosis of stroke occurring ≤30 days ago
  4. Reduced active range of movement wrist and / or finger extension
  5. Modified ashworth score at wrist and fingers ≤ 2
  6. Some initiation of gross active finger flexion
  7. At least 10 degrees passive range of motion wrist extension
  8. Considered able to learn to don / doff a SaeboGlove +/- help of willing carer
  9. Ability to engage in some independent rehabilitation +/- help of willing carer
  10. Considered able to comply with the requirements of protocol?

Exclusion criteria

  1. Presence of >5-10 degrees digital contractures
  2. Presence of other upper limb impairment that would influence participation (e.g. fixed contracture, frozen shoulder, severe arthritis or upper limb pain)
  3. Presence of other conditions likely to influence participation (e.g. medically unstable, registered blind, terminal cancer, severe mood, cognitive or language issues)
  4. Participating in another stroke rehabilitation trial

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

SaeboGlove Therapy
Experimental group
Description:
All participants will be given a SaeboGlove for a 4-week period to use along side their routine functional based training program.
Treatment:
Device: SaeboGlove

Trial contacts and locations

1

Loading...

Central trial contact

Dr Jesse Dawson; Jen Alexander

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems